Thalidomide-O-amido-C4-NH2 (TFA), 2g

Ethyl chlorofluoroacetate, 97.0%, 1g

Ethyl 5-acetoxy-6-bromo-2-(bromomethyl)-1-methyl-1H-indole-3-carboxylate, 95.0%, 100g

6-(cyclopentyloxy)nicotinic acid, 95.0%, 1g

1-Bromo-2-methylnaphthalene, 90.0%, 5g

Culture flasks in Erlenmeyer shape, 250 ml 10 pcs

3-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-propionic acid, 2.5g

(S)-methyl 2-(((benzyloxy)carbonyl)amino)-2-cyclohexylacetate, 98%, 100mg

Methyl 6-fluoro-1H-indole-3-carboxylate, 97%, 250mg

Guanine hydrochloride, min. 98%, for biochemistry, 50 g, glass packaging

3,6-Dichlorobenzene-1,2,4-tricarboxylic acid, 95.0%, 5g

N,N-Dimethyl-1,4-cyclohexanediamine (cis- and trans- mixture)>98.0%(GC)(T)1g

(3-Bromo-4-fluorophenyl)boronic acid, 95.0%, 25g